Life Sciences
Tahmidur Remura Dewey LeBoeuf’s lawyers employ a multidisciplinary approach to meeting our life sciences clients’ needs, leveraging experience in our intellectual property (IP), mergers and acquisitions, litigation, tax and other related practices. In particular, our clients in the life sciences sector benefit from our services as they face challenges specific to the sector, from strategic IP planning in a complex scientific and regulatory environment, to pipeline expansion through licensing, strategic alliances and acquisitions. Lawyers practicing in the life sciences field have technical backgrounds in molecular biology, biochemistry and related disciplines. Our clients include established pharmaceutical and biotechnology companies, start-up and emerging companies, medical device companies, clinical research organizations, philanthropic institutions, private equity firms, venture capital firms, pension funds and investment banks. Representative Clients
Abbott
Gilead
Illumina
Medicis
MedImmune
Medtronic
Merz Pharma
Novartis
Onyx Pharmaceuticals
Progenics
Pronova Biopharma
Representative Transactions
Represented Novartis in connection with the development, promotion and manufacture of emerging antiviral compounds and, in a separate transaction, the in-licensing of best-in-class siRNA technology
Represented Medimmune in its $15.6 billion acquisition by AstraZeneca
Represented King Pharmaceuticals in its successful $1.6 billion hostile offer to acquire Alpharma
Represented underwriters in IPOs, convertible securities and follow-in equity offerings by life sciences companies with an aggregate value of over $2 billion
Representative Patent Infringement Experience
The prosecution and defense of many patent cases involving medical devices such as spinal implants, laparoscopic surgical instruments and sutures, coronary stents, bioprosthetic heart valves, cardiac pacemakers and defibrillators, optics, hip and breast implants, incontinence products and medical imaging systems
The prosecution and defense of patent cases involving biologics such as monoclonal antibody technology, human papillomavirus technology, the diagnostic use of monoclonal antibodies and a tumor necrosis factor-alpha blocker
The prosecution and defense of numerous patent infringement cases involving branded pharmaceuticals, vaccines, intermediates and ophthalmic products
Click to view a complete pdf brochure describing our Life Sciences practice and representative matters.
Related Services